Protein

China Biological Reagents (Molecular Biology Reagents, Proteins and Cell Reagents) Industry Research 2023-2024 & 2028 - ResearchAndMarkets.com

Retrieved on: 
금요일, 5월 3, 2024
Biotechnology, COVID-19, Health, Science, Other Science, Protein, COVID, DSM-IV codes, Research, Molecular biology, Vaccine, Incidence, Government, Growth, Gene

The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering.
  • The China biological reagent market by category can be segmented as follows: molecular biology reagents, proteins and cell reagents.
  • In 2023, the dominant share of China biological reagent market was held by molecular biology reagents, followed by proteins and cell reagents.
  • The China biological reagents market was positively affected due to increased demand for biological reagents.

Valley Children's Receives Historic $15 Million Gift to Create Advanced Cell Therapy Program for Pediatric Cancer

Retrieved on: 
금요일, 5월 3, 2024
Cancer, Bone marrow, Protein, Haematopoietic system, Hospital, Travel, Health care, Research, History, Weapon, Acute lymphoblastic leukemia, Accreditation, Transplant, Patient, Nursing, Infection, COG, San Francisco Bay Area, Vaccine

MADERA, Calif., May 3, 2024 /PRNewswire/ -- Valley Children's Healthcare this week announced a historic donation of $15 million that will significantly enhance the hospital's ability to provide the most advanced bone marrow transplant and chimeric antigen receptor (CAR) T-cell therapy treatments to kids with cancer in the Central Valley.

Key Points: 
  • CAR T-cell therapy is an advanced genetically engineered therapy that uses the body's natural immune system to fight cancer and infections.
  • In a key CAR T-cell study in 2021, approximately 60% of children who underwent CAR T-cell therapy were cancer-free after five years.
  • The gift will support not only the establishment and accreditation of the program but also operational funding for its first 10 years.
  • "Because of this important donation, we will be able to establish a life-saving cellular and gene therapy program at Valley Children's.

Black Soldier Fly Market is Expected to Reach $3.96 Billion by 2033 - Exclusive Report by Meticulous Research®

Retrieved on: 
목요일, 5월 2, 2024
USD, BSF, Prince, Protein, Poultry, Risk, Aquaculture, Pet food, Research, Animal feed, Zebrafish, Cocoon, BSFL, Attention, Human, Diet, Salmon, Livestock, Food, Nutrient, BNP Paribas, InnovaFeed, Good, Meat, Government, Growth

In addition, expansions in developed and emerging economies provide significant opportunities for the growth of the black soldier fly market.

Key Points: 
  • In addition, expansions in developed and emerging economies provide significant opportunities for the growth of the black soldier fly market.
  • In 2024, the aquafeed segment is expected to account for the largest share of 44% of the black soldier fly market.
  • In terms of value, in 2024, Europe is expected to account for the largest share of 55% of the black soldier fly market.
  • Moreover, North America black soldier fly market is expected to witness the highest CAGR of 34.4% during the forecast period.

Black Soldier Fly Market is Expected to Reach $3.96 Billion by 2033 - Exclusive Report by Meticulous Research®

Retrieved on: 
목요일, 5월 2, 2024
USD, BSF, Prince, Protein, Poultry, Risk, Aquaculture, Pet food, Research, Animal feed, Zebrafish, Cocoon, BSFL, Attention, Human, Diet, Salmon, Livestock, Food, Nutrient, BNP Paribas, InnovaFeed, Good, Meat, Government, Growth

In addition, expansions in developed and emerging economies provide significant opportunities for the growth of the black soldier fly market.

Key Points: 
  • In addition, expansions in developed and emerging economies provide significant opportunities for the growth of the black soldier fly market.
  • In 2024, the aquafeed segment is expected to account for the largest share of 44% of the black soldier fly market.
  • In terms of value, in 2024, Europe is expected to account for the largest share of 55% of the black soldier fly market.
  • Moreover, North America black soldier fly market is expected to witness the highest CAGR of 34.4% during the forecast period.

ButcherBox Acquires Truffle Shuffle

Retrieved on: 
목요일, 5월 2, 2024
Acquisition, Michelin, Meat, The Goonies, McKinney, Texas, Protein, Shark Tank, Cooking, Teaching, Restaurant

WATERTOWN, Mass., May 2, 2024 /PRNewswire/ -- ButcherBox, the leading direct-to-consumer meat and seafood brand, today announced the acquisition of Truffle Shuffle, a virtual cook-along experience platform. The acquisition aims to boost cooking confidence in consumers across the United States, and within the ButcherBox community, as the company embraces media and community as part of its overall strategy while continuing to serve its mission of transforming the meat industry.

Key Points: 
  • WATERTOWN, Mass., May 2, 2024 /PRNewswire/ -- ButcherBox , the leading direct-to-consumer meat and seafood brand, today announced the acquisition of Truffle Shuffle , a virtual cook-along experience platform.
  • "The Truffle Shuffle team has done an incredible job bringing people together around mealtimes," said Mike Salguero, founder and CEO of ButcherBox.
  • Their approach to teaching people to cook will continue to inspire the Truffle Shuffle community and be an invaluable tool to the ButcherBox community too."
  • Truffle Shuffle will continue to operate as its own brand while bringing its vast cooking content library to ButcherBox customers to enhance their cooking experiences.

Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

Retrieved on: 
수요일, 5월 1, 2024
FDA, Protein, APC, MRNA, Risk, Moderna, News, Death, Partnership, Skin cancer, Vaccine, ASCO, Spyglass, AACR, NK, Lung cancer, Colorectal cancer, CNBC, NMIBC, Infection, DPX, Messenger, CD8, Merck, NSCLC, RSV, Autumn, Safety, Triangle, Survival, American Cancer Society, DNA, Therapy, Medicine, Melanoma, Pembrolizumab, Biology, Peanut, Cancer, A9, Interview, Immunotherapy, DSM-IV codes, HSV, Habit, Zika virus, COVID-19, Disease, Patent, Patient, Society, Acquisition, Peptide, Antigen, Immune system

VANCOUVER, BC, May 1, 2024 /PRNewswire/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society projects that by 2050, the number of people diagnosed with cancer could rise by 77%. According to experts at last year's annual American Society of Clinical Oncology (ASCO) meeting, a little-known bacteria could be behind the rising rates of cancer in people under 40, along with pointing towards bad habits such as highly-processed diets and heavy alcohol use being potential catalysts. While five-year cancer survival rates are on an upward trend, the biotech sector is racing to meet these challenges head on with new treatments and safeguards against cancer, including recent developments from companies such as BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF), Moderna, Inc. (NASDAQ: MRNA), Boundless Bio, Inc. (NASDAQ: BOLD), ImmunityBio, Inc. (NASDAQ: IBRX), and MacroGenics, Inc. (NASDAQ: MGNX).

Key Points: 
  • A new report from the American Cancer Society projects that by 2050, the number of people diagnosed with cancer could rise by 77%.
  • "We now have massive opportunities in oncology, infectious disease, allergy desensitization, and autoimmune diseases," said Kenneth Kovan, President and Chief Operating Officer of BioVaxys.
  • The joint Moderna/Merck efforts are also testing the vaccine with Keytruda against other tumor types, including non-small cell lung cancer.
  • This shot is designed to train the immune system to recognize and attack specific mutations in cancer cells.

Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

Retrieved on: 
수요일, 5월 1, 2024
FDA, Protein, APC, MRNA, Risk, Moderna, News, Death, Partnership, Skin cancer, Vaccine, ASCO, Spyglass, AACR, NK, Lung cancer, Colorectal cancer, CNBC, NMIBC, Infection, DPX, Messenger, CD8, Merck, NSCLC, RSV, Autumn, Safety, Triangle, Survival, American Cancer Society, DNA, Therapy, Medicine, Melanoma, Pembrolizumab, Biology, Peanut, Cancer, A9, Interview, Immunotherapy, DSM-IV codes, HSV, Habit, Zika virus, COVID-19, Disease, Patent, Patient, Society, Acquisition, Peptide, Antigen, Immune system

VANCOUVER, BC, May 1, 2024 /PRNewswire/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society projects that by 2050, the number of people diagnosed with cancer could rise by 77%. According to experts at last year's annual American Society of Clinical Oncology (ASCO) meeting, a little-known bacteria could be behind the rising rates of cancer in people under 40, along with pointing towards bad habits such as highly-processed diets and heavy alcohol use being potential catalysts. While five-year cancer survival rates are on an upward trend, the biotech sector is racing to meet these challenges head on with new treatments and safeguards against cancer, including recent developments from companies such as BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF), Moderna, Inc. (NASDAQ: MRNA), Boundless Bio, Inc. (NASDAQ: BOLD), ImmunityBio, Inc. (NASDAQ: IBRX), and MacroGenics, Inc. (NASDAQ: MGNX).

Key Points: 
  • A new report from the American Cancer Society projects that by 2050, the number of people diagnosed with cancer could rise by 77%.
  • "We now have massive opportunities in oncology, infectious disease, allergy desensitization, and autoimmune diseases," said Kenneth Kovan, President and Chief Operating Officer of BioVaxys.
  • The joint Moderna/Merck efforts are also testing the vaccine with Keytruda against other tumor types, including non-small cell lung cancer.
  • This shot is designed to train the immune system to recognize and attack specific mutations in cancer cells.

Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry

Retrieved on: 
수요일, 5월 1, 2024
Conditional sentence, Brain, Drug, Enzyme, Patient, Bone marrow, Acetone, Organelle, Soybean, Inflammation, Methane, Protein, Cell, Laboratory, Mineral, Pregnancy, Blood, Yolk, Health, Apoptosis, Human body, Death, Research, Vitamin, Water, Carbon, Functional food, Phospholipid, Kaifeng, Dietary fiber, Disease, Convalescence, Agonal respiration, Human, Mitochondrion, SISI, Food, Medicine, PC, Golgi, Carbohydrate, Nutrient, Beauty, Signal transduction, Temperature, Ageing, Microsome, Lipid, Cell damage, Malabsorption, Growth, Fats, Phosphorus

Cells are the basic units of life, and the health and vitality of cells directly affect the health of the entire body.

Key Points: 
  • Cells are the basic units of life, and the health and vitality of cells directly affect the health of the entire body.
  • Cells need to continuously obtain nutrients from the external environment to support their normal growth, division and metabolic activities.
  • When cells receive sufficient and balanced nutrients, they can maintain optimal conditions, perform various life activities, and maintain cell health.
  • The layout of the three major fields will create natural active water phospholipids into a super new category in the health industry.

Stowers Institute for Medical Research appoints new Assistant Investigator

Retrieved on: 
화요일, 4월 30, 2024
Science, Cancer, Investigator, Bangladesh Technical Education Board, Protein, Cell, Health, Disease, Heart, Research, NYU, Life, Medical research, Assistant, Biology, Kostov, Ribosome, Engineering, Knowledge, MIT

KANSAS CITY, Mo., April 30, 2024 /PRNewswire/ -- The Stowers Institute for Medical Research announces the appointment of Kamena Kostova, Ph.D., as its newest Principal Investigator. Kostova, an accomplished cellular and molecular biologist, will join the Institute as an Assistant Investigator in Fall 2024.

Key Points: 
  • Kamena Kostova, Ph.D., a molecular biologist from Carnegie Science, will open her lab at the Stowers Institute in Fall 2024.
  • KANSAS CITY, Mo., April 30, 2024 /PRNewswire/ -- The Stowers Institute for Medical Research announces the appointment of Kamena Kostova, Ph.D. , as its newest Principal Investigator.
  • Kostova, an accomplished cellular and molecular biologist, will join the Institute as an Assistant Investigator in Fall 2024.
  • "We are delighted to welcome and count Dr. Kamena Kostova as our newest Principal Investigator at the Stowers Institute," said Alejandro Sánchez Alvarado, Ph.D. , President and Chief Scientific Officer of the Stowers Institute.

MD Logic Health® Introduces Their New Low Molecular Bioactive Colostrum

Retrieved on: 
화요일, 4월 30, 2024
Sale, Digestion, Protein, Solubility, Pinnacle, Milk, Cytokine, MD, Logic, Probiotic, Peptide, Colostrum, Immunity, Absorption, Nutritional science, Fats, Dairy

MIAMI, April 30, 2024 /PRNewswire-PRWeb/ -- In an era where gut health is paramount, MD Logic Health® has once again raised the bar with the introduction of its Low Molecular Bioactive Colostrum), a new pinnacle in health supplements for superior gut health and overall well-being. Known for their unwavering dedication to excellence and innovation, MD Logic Health®'s latest formulation offers unparalleled potency, purity, and efficacy.

Key Points: 
  • MD Logic Health® raises the bar in gut health innovation with its new Low Molecular Bioactive Colostrum, offering unmatched potency and efficacy.
  • - Wesley Ramjeet, CEO of MD Logic Health®
    As the market's demand for effective gut health solutions intensifies, MD Logic Health® delivers a compelling answer with its Low Molecular Bioactive Colostrum.
  • The Low Molecular Bioactive Colostrum is sourced from all-natural, hormone-free grass-fed cattle maintained on a carefully selected, nutrient-rich diet.
  • MD Logic Health®'s Low Molecular Bioactive Colostrum is a revolution in wellness, designed to meet the needs of modern health-conscious consumers.